Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
Plos One
|
September 25, 2009
The AUXIN BINDING PROTEIN 1 is required for differential auxin responses mediating root growth
Alexandre Tromas, Nils Braun, Philippe Muller, et al.
Journal of Medicinal Chemistry
|
February 8, 2008
Selection of a respiratory syncytial virus fusion inhibitor clinical candidate. 2. Discovery of a morpholinopropylaminobenzimidazole derivative (TMC353121)
Jean-François Bonfanti, Christophe Meyer, Frédéric Doublet, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 18, 2003
5-imidazolyl-quinolinones, -quinazolinones and -benzo-azepinones as farnesyltransferase inhibitors
Patrick Angibaud, Xavier Bourdrez, Ann Devine, et al.
International Journal of Cardiology
|
October 28, 2016
One year clinical outcomes in patients with insulin-treated diabetes mellitus and non-insulin-treated diabetes mellitus compared to non-diabetics after deployment of the bio-engineered COMBO stent
Deborah N Kalkman, Pier Woudstra, Peter den Heijer, et al.
JACC. Cardiovascular Interventions
|
May 23, 2016
1-Year Results of the REMEDEE Registry: Clinical Outcomes After Deployment of the Abluminal Sirolimus-Coated Bioengineered (Combo) Stent in a Multicenter, Prospective All-Comers Registry
Pier Woudstra, Deborah N Kalkman, Peter den Heijer, et al.
Journal of Medicinal Chemistry
|
August 29, 2007
Selection of a respiratory syncytial virus fusion inhibitor clinical candidate, part 1: improving the pharmacokinetic profile using the structure-property relationship
Jean-François Bonfanti, Frédéric Doublet, Jérôme Fortin, et al.
Open Heart
|
August 2, 2017
Two-year clinical outcomes of patients treated with the dual-therapy stent in a 1000 patient all-comers registry
Deborah N Kalkman, Pier Woudstra, Ian B A Menown, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
February 2, 2017
Evaluation of clinical outcomes after COMBO stent treatment in patients presenting with acute coronary syndrome
Deborah N Kalkman, Pier Woudstra, Huangling Lu, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 4, 2003
Substituted azoloquinolines and -quinazolines as new potent farnesyl protein transferase inhibitors
Patrick Angibaud, Xavier Bourdrez, David W End, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions
|
October 31, 2019
Long-Term Performance of the COMBO Dual-Therapy Stent: Results from the REMEDEE Registry
Laura S Kerkmeijer, Deborah N Kalkman, Pier Woudstra, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
Plos One
|
September 25, 2009
The AUXIN BINDING PROTEIN 1 is required for differential auxin responses mediating root growth
Alexandre Tromas, Nils Braun, Philippe Muller, et al.
Journal of Medicinal Chemistry
|
February 8, 2008
Selection of a respiratory syncytial virus fusion inhibitor clinical candidate. 2. Discovery of a morpholinopropylaminobenzimidazole derivative (TMC353121)
Jean-François Bonfanti, Christophe Meyer, Frédéric Doublet, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 18, 2003
5-imidazolyl-quinolinones, -quinazolinones and -benzo-azepinones as farnesyltransferase inhibitors
Patrick Angibaud, Xavier Bourdrez, Ann Devine, et al.
International Journal of Cardiology
|
October 28, 2016
One year clinical outcomes in patients with insulin-treated diabetes mellitus and non-insulin-treated diabetes mellitus compared to non-diabetics after deployment of the bio-engineered COMBO stent
Deborah N Kalkman, Pier Woudstra, Peter den Heijer, et al.
JACC. Cardiovascular Interventions
|
May 23, 2016
1-Year Results of the REMEDEE Registry: Clinical Outcomes After Deployment of the Abluminal Sirolimus-Coated Bioengineered (Combo) Stent in a Multicenter, Prospective All-Comers Registry
Pier Woudstra, Deborah N Kalkman, Peter den Heijer, et al.
Journal of Medicinal Chemistry
|
August 29, 2007
Selection of a respiratory syncytial virus fusion inhibitor clinical candidate, part 1: improving the pharmacokinetic profile using the structure-property relationship
Jean-François Bonfanti, Frédéric Doublet, Jérôme Fortin, et al.
Open Heart
|
August 2, 2017
Two-year clinical outcomes of patients treated with the dual-therapy stent in a 1000 patient all-comers registry
Deborah N Kalkman, Pier Woudstra, Ian B A Menown, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
February 2, 2017
Evaluation of clinical outcomes after COMBO stent treatment in patients presenting with acute coronary syndrome
Deborah N Kalkman, Pier Woudstra, Huangling Lu, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 4, 2003
Substituted azoloquinolines and -quinazolines as new potent farnesyl protein transferase inhibitors
Patrick Angibaud, Xavier Bourdrez, David W End, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions
|
October 31, 2019
Long-Term Performance of the COMBO Dual-Therapy Stent: Results from the REMEDEE Registry
Laura S Kerkmeijer, Deborah N Kalkman, Pier Woudstra, et al.
Page
of 4